Cetera Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Sell |
39,375
-15,055
| -28% | -$252K | ﹤0.01% | 2742 |
|
|
2025
Q1 | $837K | Buy |
54,430
+1,325
| +2% | +$20.4K | ﹤0.01% | 2408 |
|
|
2024
Q4 | $1.17M | Sell |
53,105
-899
| -2% | -$19.8K | ﹤0.01% | 2058 |
|
|
2024
Q3 | $973K | Sell |
54,004
-6,864
| -11% | -$124K | ﹤0.01% | 2145 |
|
|
2024
Q2 | $989K | Buy |
60,868
+27,765
| +84% | +$451K | ﹤0.01% | 2084 |
|
|
2024
Q1 | $467K | Buy |
33,103
+8,629
| +35% | +$122K | ﹤0.01% | 2658 |
|
|
2023
Q4 | $256K | Sell |
24,474
-3,711
| -13% | -$38.7K | ﹤0.01% | 1885 |
|
|
2023
Q3 | $287K | Sell |
28,185
-4,642
| -14% | -$47.3K | ﹤0.01% | 1757 |
|
|
2023
Q2 | $247K | Buy |
32,827
+318
| +1% | +$2.4K | ﹤0.01% | 1864 |
|
|
2023
Q1 | $288K | Sell |
32,509
-1,328
| -4% | -$11.8K | ﹤0.01% | 1731 |
|
|
2022
Q4 | $309K | Buy |
33,837
+14,306
| +73% | +$130K | ﹤0.01% | 1652 |
|
|
2022
Q3 | $158K | Sell |
19,531
-17,790
| -48% | -$144K | ﹤0.01% | 1530 |
|
|
2022
Q2 | $281K | Sell |
37,321
-375
| -1% | -$2.82K | ﹤0.01% | 1459 |
|
|
2022
Q1 | $354K | Buy |
37,696
+9
| +0% | +$85 | 0.01% | 1387 |
|
|
2021
Q4 | $302K | Buy |
37,687
+660
| +2% | +$5.29K | ﹤0.01% | 1488 |
|
|
2021
Q3 | $361K | Sell |
37,027
-698
| -2% | -$6.81K | 0.01% | 1320 |
|
|
2021
Q2 | $373K | Buy |
37,725
+1,388
| +4% | +$13.7K | 0.01% | 1287 |
|
|
2021
Q1 | $419K | Sell |
36,337
-3,681
| -9% | -$42.4K | 0.01% | 1076 |
|
|
2020
Q4 | $386K | Buy |
+40,018
| New | +$386K | 0.01% | 1099 |
|
|
2017
Q3 | – | Sell |
-11,168
| Closed | -$373K | – | 409 |
|
|
2017
Q2 | $373K | Buy |
+11,168
| New | +$373K | 0.09% | 271 |
|